| Aug 2 |
Wall Street Analysts Think Genmab (GMAB) Could Surge 45.08%: Read This Before Placing a Bet
|
| Aug 2 |
Buy 2 Biotech Bigwigs Set to Gain on Possible Earnings Beat
|
| Aug 1 |
What 8 Analyst Ratings Have To Say About Genmab
|
| Jul 31 |
J&J wins another FDA label expansion for multiple myeloma therapy
|
| Jul 29 |
All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy
|
| Jul 25 |
GMAB vs. CSLLY: Which Stock Is the Better Value Option?
|
| Jul 17 |
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024
|
| Jul 15 |
Genmab upgraded at RBC on valuation
|
| Jul 9 |
GMAB or TECH: Which Is the Better Value Stock Right Now?
|
| Jul 8 |
GMAB vs. TECH: Which Stock Is the Better Value Option?
|
